290 related articles for article (PubMed ID: 23488746)
1. Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.
Ullmer C; Alvarez Sanchez R; Sprecher U; Raab S; Mattei P; Dehmlow H; Sewing S; Iglesias A; Beauchamp J; Conde-Knape K
Br J Pharmacol; 2013 Jun; 169(3):671-84. PubMed ID: 23488746
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.
Hunt JE; Billeschou A; Windeløv JA; Hartmann B; Ullmer C; Holst JJ; Kissow H
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G980-G987. PubMed ID: 32308039
[TBL] [Abstract][Full Text] [Related]
3. Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells.
Habib AM; Richards P; Rogers GJ; Reimann F; Gribble FM
Diabetologia; 2013 Jun; 56(6):1413-6. PubMed ID: 23519462
[TBL] [Abstract][Full Text] [Related]
4. Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors.
Brighton CA; Rievaj J; Kuhre RE; Glass LL; Schoonjans K; Holst JJ; Gribble FM; Reimann F
Endocrinology; 2015 Nov; 156(11):3961-70. PubMed ID: 26280129
[TBL] [Abstract][Full Text] [Related]
5. Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.
Billing LJ; Smith CA; Larraufie P; Goldspink DA; Galvin S; Kay RG; Howe JD; Walker R; Pruna M; Glass L; Pais R; Gribble FM; Reimann F
Mol Metab; 2018 Oct; 16():65-75. PubMed ID: 30104166
[TBL] [Abstract][Full Text] [Related]
6. Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist.
Grunddal KV; Diep TA; Petersen N; Tough IR; Skov LJ; Liu L; Buijink JA; Mende F; Jin C; Jepsen SL; Sørensen LME; Achiam MP; Strandby RB; Bach A; Hartmann B; Frimurer TM; Hjorth SA; Bouvier M; Cox H; Holst B
Mol Metab; 2021 Jul; 49():101207. PubMed ID: 33711555
[TBL] [Abstract][Full Text] [Related]
7. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ
Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; Nøhr MK; Egerod KL; Nawrocki AR; Kowalski T; Howard AD; Poulsen SS; Offermanns S; Bäckhed F; Holst JJ; Holst B; Schwartz TW
Endocrinology; 2016 Jan; 157(1):176-94. PubMed ID: 26469136
[TBL] [Abstract][Full Text] [Related]
9. Endogenous PYY and GLP-1 mediate l-glutamine responses in intestinal mucosa.
Joshi S; Tough IR; Cox HM
Br J Pharmacol; 2013 Nov; 170(5):1092-101. PubMed ID: 23992397
[TBL] [Abstract][Full Text] [Related]
10. Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.
Kuhre RE; Wewer Albrechtsen NJ; Larsen O; Jepsen SL; Balk-Møller E; Andersen DB; Deacon CF; Schoonjans K; Reimann F; Gribble FM; Albrechtsen R; Hartmann B; Rosenkilde MM; Holst JJ
Mol Metab; 2018 May; 11():84-95. PubMed ID: 29656109
[TBL] [Abstract][Full Text] [Related]
11. Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Nunez DJ; Bush MA; Collins DA; McMullen SL; Gillmor D; Apseloff G; Atiee G; Corsino L; Morrow L; Feldman PL
PLoS One; 2014; 9(4):e92494. PubMed ID: 24699248
[TBL] [Abstract][Full Text] [Related]
12. Role of enteroendocrine L-cells in arginine vasopressin-mediated inhibition of colonic anion secretion.
Pais R; Rievaj J; Meek C; De Costa G; Jayamaha S; Alexander RT; Reimann F; Gribble F
J Physiol; 2016 Sep; 594(17):4865-78. PubMed ID: 27037495
[TBL] [Abstract][Full Text] [Related]
13. The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes.
Brønden A; Albér A; Rohde U; Gasbjerg LS; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2018 Feb; 20(2):362-369. PubMed ID: 28786523
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation.
Kim K; Park M; Lee YM; Rhyu MR; Kim HY
Arch Pharm Res; 2014; 37(9):1193-200. PubMed ID: 24590628
[TBL] [Abstract][Full Text] [Related]
15. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
16. L-arginine promotes gut hormone release and reduces food intake in rodents.
Alamshah A; McGavigan AK; Spreckley E; Kinsey-Jones JS; Amin A; Tough IR; O'Hara HC; Moolla A; Banks K; France R; Hyberg G; Norton M; Cheong W; Lehmann A; Bloom SR; Cox HM; Murphy KG
Diabetes Obes Metab; 2016 May; 18(5):508-18. PubMed ID: 26863991
[TBL] [Abstract][Full Text] [Related]
17. L-Cell Differentiation Is Induced by Bile Acids Through GPBAR1 and Paracrine GLP-1 and Serotonin Signaling.
Lund ML; Sorrentino G; Egerod KL; Kroone C; Mortensen B; Knop FK; Reimann F; Gribble FM; Drucker DJ; de Koning EJP; Schoonjans K; Bäckhed F; Schwartz TW; Petersen N
Diabetes; 2020 Apr; 69(4):614-623. PubMed ID: 32041793
[TBL] [Abstract][Full Text] [Related]
18. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents.
Psichas A; Sleeth ML; Murphy KG; Brooks L; Bewick GA; Hanyaloglu AC; Ghatei MA; Bloom SR; Frost G
Int J Obes (Lond); 2015 Mar; 39(3):424-9. PubMed ID: 25109781
[TBL] [Abstract][Full Text] [Related]
19. Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents.
Christiansen CB; Trammell SAJ; Wewer Albrechtsen NJ; Schoonjans K; Albrechtsen R; Gillum MP; Kuhre RE; Holst JJ
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G574-G584. PubMed ID: 30767682
[TBL] [Abstract][Full Text] [Related]
20. SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity.
Ueno H; Ito R; Abe SI; Ookawara M; Miyashita H; Ogino H; Miyamoto Y; Yoshihara T; Kobayashi A; Tsujihata Y; Takeuchi K; Watanabe M; Yamada Y; Maekawa T; Nishigaki N; Moritoh Y
J Pharmacol Exp Ther; 2019 Aug; 370(2):172-181. PubMed ID: 31182471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
